Initial outcomes with image-guided partial breast irradiation delivered with intensity-modulated radiation therapy
- PMID: 31502371
- DOI: 10.1111/tbj.13544
Initial outcomes with image-guided partial breast irradiation delivered with intensity-modulated radiation therapy
Abstract
Patients were treated at a single institution to a dose of 30 Gy in five fractions delivered every other day using image-guided intensity modulated radiation therapy (IMRT) partial breast irradiation. A total of 34 patients were treated with a median follow-up of 4.6 months. The rate of acute Grade 1 dermatitis was 23.5% (n = 8), and Grade 1 fatigue was 17.6% (n = 6), with no Grade 2 or higher acute toxicities. The rate of chronic Grade 1 dermatitis was 25.0% (n = 6), Grade 1 fat necrosis 4.2% (n=1), with no patients demonstrating other chronic toxicities. Image-guided APBI delivered with IMRT is associated with low rates of acute and chronic toxicity though additional follow-up is warranted.
Keywords: breast cancer; breast conserving therapy; partial breast irradiation.
© 2019 Wiley Periodicals, Inc.
Similar articles
-
Accelerated partial breast irradiation with 3-dimensional conformal and image-guided intensity-modulated radiotherapy following breast conserving surgery - 7-Year results of a phase II trial.Breast. 2020 Dec;54:222-228. doi: 10.1016/j.breast.2020.10.010. Epub 2020 Oct 30. Breast. 2020. PMID: 33161336 Free PMC article. Clinical Trial.
-
Accelerated partial breast irradiation is safe and effective using intensity-modulated radiation therapy in selected early-stage breast cancer.Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):2104-10. doi: 10.1016/j.ijrobp.2011.02.024. Epub 2011 Jun 2. Int J Radiat Oncol Biol Phys. 2012. PMID: 21640490
-
A phase I/II study piloting accelerated partial breast irradiation using CT-guided intensity modulated radiation therapy in the prone position.Radiother Oncol. 2013 Aug;108(2):215-9. doi: 10.1016/j.radonc.2013.05.039. Epub 2013 Aug 7. Radiother Oncol. 2013. PMID: 23932158 Clinical Trial.
-
Cardiac dose sparing and avoidance techniques in breast cancer radiotherapy.Radiother Oncol. 2014 Jul;112(1):9-16. doi: 10.1016/j.radonc.2014.04.009. Epub 2014 May 8. Radiother Oncol. 2014. PMID: 24813095 Review.
-
Partial breast re-irradiation for local recurrence of breast carcinoma: Benefit and long term side effects.Breast. 2013 Aug;22 Suppl 2:S141-6. doi: 10.1016/j.breast.2013.07.026. Breast. 2013. PMID: 24074775 Review.
Cited by
-
The initial experience of MRI-guided precision prone breast irradiation with daily adaptive planning in treating early stage breast cancer patients.Front Oncol. 2022 Nov 23;12:1048512. doi: 10.3389/fonc.2022.1048512. eCollection 2022. Front Oncol. 2022. PMID: 36505797 Free PMC article.
References
REFERENCES
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7-34.
-
- Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241.
-
- Correa C, Harris EE, Leonardi MC, et al. Accelerated partial breast irradiation: Executive summary for the update of an astro evidence-based consensus statement. Pract Radiat Oncol. 2017;7:73-79.
-
- Shah C, Vicini F, Shaitelman SF, et al. The american brachytherapy society consensus statement for accelerated partial-breast irradiation. Brachytherapy. 2018;17:154-170.
-
- Polgár C, Ott OJ, Hildebrandt G, et al. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial. Lancet Oncol. 2017;18:259-268.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
